Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tradjenta (linagliptin) and Actos (pioglitazone) are both oral medications used to treat Type 2 diabetes, but they belong to different drug classes and work in distinct ways. Tradjenta helps your body produce more insulin and reduce sugar production by blocking the DPP-4 protein. In contrast, Actos improves your body's ability to use insulin, can raise "good" cholesterol levels, and lower the risk of heart attack or stroke. Tradjenta is typically taken once daily without regard to meals and is known for causing few side effects, such as runny nose and diarrhea. Actos is also taken once daily and can be taken with or without food. Actos has a higher risk of causing weight gain, fluid build-up, and even bladder cancer, whereas Tradjenta can cause severe joint pain and has a risk of pancreatitis.
Tradjenta (linagliptin)
Pioglitazone (Actos)
Tradjenta (linagliptin)
Pioglitazone (Actos)
Summary of Tradjenta vs. Actos
Summary for DDP-4 inhibitor
Prescription only
Tradjenta (linagliptin) is a prescription medication that's used along with a balanced diet and exercise to manage blood sugar levels in adults with Type 2 diabetes. It's a type of diabetes medication called a dipeptidyl peptidase-4 (DPP-4) inhibitor. The dose is 5 mg (1 tablet) that's taken by mouth once per day. Tradjenta (linagliptin) doesn't cause many side effects but can sometimes include runny nose, sneezing, and diarrhea. As of 2024, Tradjenta (linagliptin) is available as a brand-name medication only; there's no generic version yet.
Summary for Thiazolidinedione
Prescription only
Pioglitazone (Actos) is an oral medication used to treat Type 2 diabetes in adults, along with diet and exercise. It's a thiazolidinedione, which works by helping your body respond better to insulin. This medication is taken by mouth once a day and is available in both brand and generic forms. Side effects include headache, swelling in the body, and weight gain. There's also a serious warning that it can cause or worsen heart failure.